126 related articles for article (PubMed ID: 4784505)
41. Placental lactogen and growth hormone receptors in human fetal tissues: relationship to fetal plasma human placental lactogen concentrations and fetal growth.
Hill DJ; Freemark M; Strain AJ; Handwerger S; Milner RD
J Clin Endocrinol Metab; 1988 Jun; 66(6):1283-90. PubMed ID: 3372688
[TBL] [Abstract][Full Text] [Related]
42. Observations on the use of solid-phase-coupled antibodies in the radioimmunoassay of human placental lactogen.
Gardner J; Bailey G; Chard T
Biochem J; 1974 Mar; 137(3):469-76. PubMed ID: 4138810
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure and site 1 binding energetics of human placental lactogen.
Walsh ST; Kossiakoff AA
J Mol Biol; 2006 May; 358(3):773-84. PubMed ID: 16546209
[TBL] [Abstract][Full Text] [Related]
44. Sn-1,2-diacylglycerols and phorbol esters stimulate the synthesis and release of human placental lactogen from placental cells: a role for protein kinase C.
Harman I; Zeitler P; Ganong B; Bell RM; Handwerger S
Endocrinology; 1986 Sep; 119(3):1239-44. PubMed ID: 3732165
[TBL] [Abstract][Full Text] [Related]
45. [Value and significance of HPL (human placental lactogen) determination in the course of the routine examination of healthy pregnant women].
Gáti I; Doszpod J; Hadnagy J; Preisz J; Szigetvári I; Cseh I; Rákóczi I; Kereszti J; Egyed J
Acta Paediatr Acad Sci Hung; 1976; 17(3):233-6. PubMed ID: 1027322
[No Abstract] [Full Text] [Related]
46. [Influence of allylestrenol on hpl serum levels in high-risk pregnancies (author's transl)].
Spona J; Müller-Tyl E; Leodolter S
Z Geburtshilfe Perinatol; 1976 Oct; 180(5):356-62. PubMed ID: 969796
[TBL] [Abstract][Full Text] [Related]
47. [Relation of human placental lactogenic hormone (HPL) with prolactin and human hypophyseal growth hormone].
Dăssler CG
Dtsch Gesundheitsw; 1970 Jun; 25(22):1035-9. PubMed ID: 5523847
[No Abstract] [Full Text] [Related]
48. Characterization and partial purification of a serum protein which stimulates the release of human placental lactogen in vitro.
Barrett J; Golander A; Conn PM; Handwerger S
J Clin Endocrinol Metab; 1986 Aug; 63(2):336-42. PubMed ID: 3722325
[TBL] [Abstract][Full Text] [Related]
49. [The significance of radioimmunological HPL determination in obstetrics (author's transl)].
Scholz K; Gant H; Ladurner D; Geir W
Wien Klin Wochenschr; 1975 Sep; 87(16):515-21. PubMed ID: 818820
[TBL] [Abstract][Full Text] [Related]
50. [Radioimmunologic determination of placental lactogen hormone in amniotic fluid drawn by amniocentesis in near-term pregnancies].
Hechtermans R; L'Hermite-Baleriaux M; Delhaye C; Jacob D; Flamme P
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):328-30. PubMed ID: 4681536
[No Abstract] [Full Text] [Related]
51. [Human chorionic somatommamotropins (HCS or HPL) : radioimmunologic determination and clinical significance].
Albertini A; Ghielmi S; Signorini C; Pecorelli S; Belletti S
Quad Sclavo Diagn; 1975 Jun; 11(2):382-96. PubMed ID: 1223944
[TBL] [Abstract][Full Text] [Related]
52. [Diagnostic assessment of normal and risk pregnancies. 1. Comparison of two radioimmunological methods for the determination of human placental lactogen (author's transl)].
Musch K; Wolf AS; Lauritzen C
Geburtshilfe Frauenheilkd; 1978 May; 38(5):365-70. PubMed ID: 648860
[TBL] [Abstract][Full Text] [Related]
53. Reassessment of the role of human placental lactogen in physiological non-pregnant and pathological conditions.
Madersbacher S; Untergasser G; Gerth R; Hermann M; Schwärzler P; Dirnhofer S; Berger P
Exp Clin Endocrinol Diabetes; 1998; 106(1):61-7. PubMed ID: 9516062
[TBL] [Abstract][Full Text] [Related]
54. Potential for error in a radioimmunometric assay for placental lactogen.
Neethling AC; Finnie P
Clin Chem; 1985 Jun; 31(6):1073. PubMed ID: 3995733
[No Abstract] [Full Text] [Related]
55. [Usefulness of serum HPL determination as an indicator of placental function and fetal growth].
Yamaguchi H; Nishiyama Y; Nose Y; Sugiyama Y
Horumon To Rinsho; 1979 Feb; 27(2):191-6. PubMed ID: 428130
[No Abstract] [Full Text] [Related]
56. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy.
Caufriez A; Frankenne F; Englert Y; Golstein J; Cantraine F; Hennen G; Copinschi G
Am J Physiol; 1990 Jun; 258(6 Pt 1):E1014-9. PubMed ID: 2360624
[TBL] [Abstract][Full Text] [Related]
57. Treatment of radioimmunoassay data: a computer program for curvefitting and dose interpolation using orthogonal polynomials.
Nemoz C; Faure A; Bizzollon C; Site J
Comput Programs Biomed; 1978 Jun; 8(2):99-109. PubMed ID: 668312
[TBL] [Abstract][Full Text] [Related]
58. Computer program for evaluation, physicochemical characterization and optimization of competitive protein binding assays: comparison of four curve-fitting models in peptide and steroid radioimmunoassays.
Schöneshöfer M
Clin Chim Acta; 1977 Jun; 77(2):101-15. PubMed ID: 890938
[TBL] [Abstract][Full Text] [Related]
59. Statistical characterization of the random errors in the radioimmunoassay dose--response variable.
Rodbard D; Lenox RH; Wray HL; Ramseth D
Clin Chem; 1976 Mar; 22(3):350-8. PubMed ID: 175978
[TBL] [Abstract][Full Text] [Related]
60. A computer program for mathematical treatment of data in radioimmunoassay.
Motta M; Esposti AD
Comput Programs Biomed; 1981; 13(1-2):121-9. PubMed ID: 7285559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
